Barely Significant
← all excerpts

The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis.

PLoS One · 2025 · PMC12617863 · PMID 41237182

Europe PMCDOI
1
hedged sentence
0.0000
closest p · 0.0× alpha
0.0000
boldest claim

The sentences

highly significantp < 0.00001actually significant
The overall effect was highly significant (Z = 7.70, p < 0.00001), further supporting the effectiveness of this dosage.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.